Logo.png
Stereotaxis Announces Ex-Rights Date of November 4, 2013 for Rights Offering
November 04, 2013 14:41 ET | Stereotaxis, Inc.
ST. LOUIS, Nov. 4, 2013 (GLOBE NEWSWIRE) -- Pursuant to its previously-announced rights offering, all stockholders and certain warrant holders of Stereotaxis, Inc. (Nasdaq:STXS) received subscription...
Logo.png
Stereotaxis Announces Record Date for Rights Offering
October 29, 2013 10:43 ET | Stereotaxis, Inc.
ST. LOUIS, Oct. 29, 2013 (GLOBE NEWSWIRE) -- Stereotaxis, Inc. (Nasdaq:STXS) announced today that it has fixed 5:00 p.m. New York City time on October 31, 2013 as the record date for determination of...
Logo.png
Stereotaxis Niobe(R) System Receives Highest Reimbursement Classification in Japan
October 23, 2013 06:31 ET | Stereotaxis, Inc.
ST. LOUIS, Oct. 23, 2013 (GLOBE NEWSWIRE) -- Stereotaxis, Inc. (Nasdaq:STXS) announced today that the Ministry of Health, Labor and Welfare (MHLW) in Japan has classified its Niobe® Magnetic...
Logo.png
Stereotaxis Announces Preliminary Third Quarter 2013 Financial Results in Preparation for Rights Offering
October 23, 2013 06:30 ET | Stereotaxis, Inc.
ST. LOUIS, Oct. 23, 2013 (GLOBE NEWSWIRE) -- Stereotaxis, Inc. (Nasdaq:STXS) today released certain preliminary financial results for the 2013 third quarter in anticipation of its previously announced...
Logo.png
Stereotaxis Announces Renewal of Silicon Valley Bank Credit Facility
September 03, 2013 06:30 ET | Stereotaxis, Inc.
ST. LOUIS, Sept. 3, 2013 (GLOBE NEWSWIRE) -- Stereotaxis, Inc. (Nasdaq:STXS) announced today that it has completed the renewal of its revolving credit facility with Silicon Valley Bank (SVB). Under...
Logo.png
Stereotaxis Announces Listing Transfer to NASDAQ Capital Market
August 16, 2013 06:30 ET | Stereotaxis, Inc.
ST. LOUIS, Aug. 16, 2013 (GLOBE NEWSWIRE) -- Stereotaxis, Inc. (Nasdaq:STXS) today announced that it received a positive determination from the NASDAQ Listing Qualifications Panel (the "Panel") on...
Logo.png
Stereotaxis Reports Second Quarter 2013 Financial Results; Announces Capital Transactions
August 08, 2013 06:30 ET | Stereotaxis, Inc.
-Achieves 49% Sequential Improvement in System Revenue- -Secures Two Niobe® ES Orders- -Narrows Operating Loss to $(1.8) Million- -Obtains U.S. FDA Clearance of Vdrive™ with...
Logo.png
Stereotaxis Receives FDA Clearance of Vdrive(TM) with V-Sono(TM) System
July 29, 2013 16:05 ET | Stereotaxis, Inc.
ST. LOUIS, July 29, 2013 (GLOBE NEWSWIRE) -- Stereotaxis, Inc. (Nasdaq:STXS) announced today that it has been granted 510(k) clearance by the Food and Drug Administration (FDA) to market its...
Logo.png
Stereotaxis Reports First Quarter 2013 Financial Results
May 13, 2013 16:05 ET | Stereotaxis, Inc.
-Year-over-Year Operating Loss Improves by 14%- -Open Positions in Sales Organization Impact Revenue Growth and New Orders- -Cash Burn is reduced to $1.1 M, a 73% YOY Improvement- -Operating...
Logo.png
Stereotaxis to Highlight Enhanced Technology and Results at HRS 2013 in Denver
May 07, 2013 06:30 ET | Stereotaxis, Inc.
ST. LOUIS, May 7, 2013 (GLOBE NEWSWIRE) -- Stereotaxis, Inc. (Nasdaq:STXS) announced that it will highlight the milestones and clinical results achieved with its cutting-edge Epoch™ platform, as...